Smith Jason Drew

Smith Jason Drew's trades of Urogen Pharma Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-04 2025-01-31 S Sale
2,767 -7.8%
11.14
USD 30,824
2,767 -7.8% 11.14 USD 30,824
2025-02-04 2025-01-31 S Sale
3,354 -10.1%
11.14
USD 37,364
3,354 -10.1% 11.14 USD 37,364
2025-02-04 2025-01-31 S Sale
1,258 -4.5%
11.14
USD 14,014
1,258 -4.5% 11.14 USD 14,014
2024-09-12 2024-09-09 S Sale
1,521 -5.7%
13.08
USD 19,895
1,521 -5.7% 13.08 USD 19,895
2024-02-02 2024-01-31 S Sale
3,328 -12.4%
15.74
USD 52,383
3,328 -12.4% 15.74 USD 52,383
2024-02-02 2024-01-31 S Sale
1,248 -5.9%
15.74
USD 19,644
1,248 -5.9% 15.74 USD 19,644
2024-02-02 2024-01-31 S Sale
417 -2.2%
15.74
USD 6,564
417 -2.2% 15.74 USD 6,564
2023-09-05 2023-08-31 S Sale
3,800 -17.1%
18.01
USD 68,438
3,800 -17.1% 18.01 USD 68,438
2023-02-02 2023-01-31 S Sale
1,227 -8.1%
10.12
USD 12,417
1,227 -8.1% 10.12 USD 12,417
2023-02-02 2023-01-31 S Sale
409 -3.1%
10.12
USD 4,139
409 -3.1% 10.12 USD 4,139
2022-09-02 2022-08-31 S Sale
3,606 -22.8%
7.21
USD 25,999
3,606 -22.8% 7.21 USD 25,999
2022-02-02 2022-01-31 S Sale
414 -5.3%
7.58
USD 3,138
414 -5.3% 7.58 USD 3,138
2021-12-02 2021-11-30 S Sale
3,803 -35.1%
12.03
USD 45,750
3,803 -35.1% 12.03 USD 45,750
2021-05-18 2021-05-17 B Purchase
2,500 +inf%
15.71
USD 39,275
2,500 +inf% 15.71 USD 39,275
// ... existing code ... // ... rest of the file ...